Zacks Investment Research The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Is Aligos Therapeutics, Inc. (ALGS) one of those stocks right...\n more…
Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report)'s share price gapped down prior to trading on Friday . The stock had previously closed at $11.94, but opened at $11.70. Aligos Therapeutics...\n more…
Ticker Report Shares of Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) gapped down prior to trading on Friday . The stock had previously closed at $13.16, but opened at $12.83. Aligos Therapeutics...\n more…
Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) was the recipient of a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling...\n more…
Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Get Free Report) saw unusually-high trading volume on Thursday . Approximately 25,663 shares traded hands during mid-day trading, an increase of 64% from the...\n more…
Ticker Report Aligos Therapeutics, Inc. (NASDAQ:ALGS - Free Report) - Research analysts at HC Wainwright issued their Q3 2024 earnings per share (EPS) estimates for shares of Aligos Therapeutics in a research note...\n more…